Pranada Biopharma: Emerging Service Aggregator In The Pharmaceutical Industry

Lalu Joshi

Managing Director

Lalu Joshi

Managing Director

According to India Ratings & Research, the Indian pharmaceutical market revenue is expected to be over 12% Y-o-Y in FY 2022. The growth is being influenced by a number of factors. The pandemic has caused widespread health awareness not only across the country, but the entire world. This has given way to the emergence of new pharmaceutical products in the market that needs proper overseeing to avoid any critical quality issue.

A lot of service oriented operations like advancement, enlistment, assembling, showcasing and several others need to be in line in order to drive the product to the right direction. The industry is in need of players who can perform the former operations seamlessly and add value to the industry as a whole. PranadaBiopharma from Mumbai is dedicated to convey inventive pharmaceutical items at affordable costs to serve each one in most ideal way.

Lalu Joshi, Managing Director, PranadaBiopharma says, “We specialize in providing high quality products that can improve the health and quality of life of people across the globe at reasonable prices. Our team specializes in developing generic similars, upgrading formulation efficiency and improving drug delivery systems. We have strategic tie ups in place to fuel its expansion.”

Delivery Excellence
The company offers services in exclusive domains like pre-formulation studies, complete formulation, stability studies, technology transfers, dossier development and product registration. With a keen eye on the global scenario, PranadaBiopharma continuously invests on R&D to come up with advanced products that would suit the changing needs of the market. The team takes a shot at new dynamic substances, generics, and patent non encroaching items for US, Europe, Australia and other developing markets. The company is in the process of creating different measurements shapes like Immediate discharge tablets, Delayed discharge tablets, Extended discharge tablets, Hard gelatin Capsules, Soft gelatin containers, Liquid orals, Semi solids, and so forth.

The MD mentions, “The analytical research and development department of our company works as a solid support system for all the formative work offering help for Active Pharmaceutical Ingredients (API) and Formulation Development. The division is all around outfitted with profoundly complex instruments like NMR, XRD, LCMS, High Performance Liquid Chromatography, Gas Chromatography, Differential examining calorimeter, UV spectrophotometers, infra-red spectrophotometer, disintegration mechanical assembly and Particle measure analyser and many others.” For Pranada, the workforce has been the core strength and backbone of the company with a team of 50+ experienced personnel in the R&D department. The team also constitutes of experienced as well as veteran pharmacists, chemists and scientists. The company is always in the process of upgrading themselves in the domain cross difficult hurdles to achieve something good. All the employees are aided in best in class ways so that they remain motivated in reaching the best of their abilities and come up with products that will add value to the pharmaceutical industry as a whole.

The team takes a shot at new dynamic substances, generics, and patent non encroaching items for US, Europe, Australia and other developing markets
Lalu Joshi //Managing Director

Future Endeavour
Speaking of the future of the company, the MD concludes, “We envision becoming a fully integrated pharmaceutical company and a leader in this ever expanding market through innovation, better product profiles, ensuring quality products with timely delivery. The Indian pharmaceutical industry is the world's 3rd largest by volume and 14th largest in terms of value which we want to bring to 1st largest by volume and in first five in terms of value.”